Overall, there is still much unknown about the role of genetic variability in cholinergic and nicotine metabolism genes in smoking cessation. Research examining the cellular and molecular mechanisms of SNPs and haplotypes in genes associated with smoking cessation phenotypes can facilitate the development of novel pharmacotherapies and the delivery of personalized smoking cessation treatment.
